Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Four Rivers Clinical Research
mi
from
Paducah, KY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Four Rivers Clinical Research
mi
from
Paducah, KY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Louisiana State University Health Sciences Center
mi
from
Shreveport, LA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Louisiana State University Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Tulane Medical Center
mi
from
New Orleans, LA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Tulane Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Green Clinic LLC
mi
from
Ruston, LA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Green Clinic LLC
mi
from
Ruston, LA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Louisiana State University Health Sciences Center-Shreveport
mi
from
Shreveport, LA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Louisiana State University Health Sciences Center-Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Northwest Louisiana Nephrology
mi
from
Shreveport, LA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Northwest Louisiana Nephrology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Maine Nephrology Associates
mi
from
Portland, ME
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Maine Nephrology Associates
mi
from
Portland, ME
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Anne Arundel Medical Center
mi
from
Annapolis, MD
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Anne Arundel Medical Center
mi
from
Annapolis, MD
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
A. Kaldun Nossuli
mi
from
Bethesda, MD
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
A. Kaldun Nossuli
mi
from
Bethesda, MD
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Biolab Research, LLC
mi
from
Rockville, MD
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Biolab Research, LLC
mi
from
Rockville, MD
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Western New England Renal & Transplant Associates, PC
mi
from
Springfield, MA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Western New England Renal & Transplant Associates, PC
mi
from
Springfield, MA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Fallon Clinic, Division of Renal Medicine
mi
from
Worchester, MA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Fallon Clinic, Division of Renal Medicine
mi
from
Worchester, MA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Alzohaili Medical Consultants
mi
from
Dearborn, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Alzohaili Medical Consultants
mi
from
Dearborn, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
St. Clair Specialty Physicians
mi
from
Detroit, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
St. Clair Specialty Physicians
mi
from
Detroit, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Henry Ford Hospital
mi
from
Detroit, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Apex Medical Research
mi
from
Flint, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Apex Medical Research
mi
from
Flint, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Hurley Medical Center
mi
from
Flint, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Troy Internal Medicine, PC, Research Department
mi
from
Troy, MI
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Troy Internal Medicine, PC, Research Department
mi
from
Troy, MI
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Twin Cities Clinical Research
mi
from
Brooklyn Center, MN
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Twin Cities Clinical Research
mi
from
Brooklyn Center, MN
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Clinical Research Consultants
mi
from
Kansas City, MO
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Clinical Research Consultants
mi
from
Kansas City, MO
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
KCVAMC Kansas City VA Medical Center
mi
from
Kansas City, MO
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
KCVAMC Kansas City VA Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Nebraska Nephrolgy Research Institute
mi
from
Lincoln, NE
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Nebraska Nephrolgy Research Institute
mi
from
Lincoln, NE
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Creighton Nephrology
mi
from
Omaha, NE
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Creighton Nephrology
mi
from
Omaha, NE
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Omaha VA Medical Center
mi
from
Omaha, NE
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Omaha VA Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Kidney Speciality of Southern Nevada
mi
from
Las Vegas, NV
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Kidney Speciality of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Sierra Nevada Nephrology
mi
from
Reno, NV
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Sierra Nevada Nephrology
mi
from
Reno, NV
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Hypertension and Nephrology Associates, PA
mi
from
Eatontown, NJ
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Hypertension and Nephrology Associates, PA
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Jacobi Medical Center
mi
from
Bronx, NY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Jacobi Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Nephrology & Hyptertension Associates, PC
mi
from
Bronx, NY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Nephrology & Hyptertension Associates, PC
mi
from
Bronx, NY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Eliezer L Parnes, MD
mi
from
Brooklyn, NY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Eliezer L Parnes, MD
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Nephrology Associates, PC
mi
from
Flushing, NY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Nephrology Associates, PC
mi
from
Flushing, NY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
The Rogosin Institute
mi
from
, NY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
The Rogosin Institute
mi
from
, NY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Columbia University Medical Center
mi
from
New York, NY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
New York Harbor Healthcare
mi
from
New York City, NY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
New York Harbor Healthcare
mi
from
New York City, NY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Hypertesnion and Renal Research Group
mi
from
Orchard Park, NY
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Hypertesnion and Renal Research Group
mi
from
Orchard Park, NY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Mountain Kidney and Hypertension Associates
mi
from
Asheville, NC
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Mountain Kidney and Hypertension Associates
mi
from
Asheville, NC
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Capital Nephrology Associates, PA
mi
from
Cary, NC
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Capital Nephrology Associates, PA
mi
from
Cary, NC
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Durham Nephrology Associates
mi
from
Durham, NC
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Durham Nephrology Associates
mi
from
Durham, NC
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Duke Nephrology
mi
from
Durham, NC
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Duke Nephrology
mi
from
Durham, NC
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Pharmquest
mi
from
Greensboro, NC
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Pharmquest
mi
from
Greensboro, NC
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Eastern Nephrology Associates
mi
from
Greenville, NC
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Eastern Nephrology Associates
mi
from
Greenville, NC
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Physician's East
mi
from
Greenville, NC
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Physician's East
mi
from
Greenville, NC
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
DownEast Medical Associates, P.A.
mi
from
Morehead City, NC
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
DownEast Medical Associates, P.A.
mi
from
Morehead City, NC
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Capital Nephrology Associates
mi
from
Raleigh, NC
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Capital Nephrology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Nephrology Associates, PLLC
mi
from
Winston-Salem, NC
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Nephrology Associates, PLLC
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Odyssey Research
mi
from
Bismarck, ND
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Odyssey Research
mi
from
Bismarck, ND
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Cincinnati VA Medical Center
mi
from
Cincinnati, OH
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Cincinnati VA Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Cleveland Clinic
mi
from
Cleveland, OH
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials